News & Events


See the BD Calendar of Events


7 July, 2010
Launch of BD BACTEC™ MGIT™ 320 System Expands TB Detection Worldwide

23 June, 2010
BD Announces European Launch of the BD MAX™ System for Molecular Diagnostics

29 March, 2010
ECCMID 2010 - Come and visit us at the BD booth no. 561

8 February, 2010
BD Expands Diagnostic Testing Offerings in Women's Health

8 January, 2010
Wishing for the easiest solution: from specimen collection to a rapid diagnosis…

7 January, 2010
Help women prevent Cervical Cancer

20 November, 2009
BD Completes Acquisition of HandyLab, Inc.

30 October, 2009
Make the BD FocalPoint™ GS Imaging System your guide in cervical cytology screening.

30 October, 2009
Your Global Partner for Industrial Excellence

23 October, 2009
BD Announces Agreement to Acquire HandyLab, Inc.

1 October, 2009
Maximizing Productivity with BD Phoenix™ AP »

1 October, 2009
Launch of BD MGIT™ TBc Identification Test in Africa and the European Union »

1 October, 2009
Reliable detection, identification and screening with BD BBL™ CHROMagar™ Products.»

28 September, 2009
BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer

12 September, 2009
Introducing the BD FocalPoint™ GS Imaging System

6 August, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio »

18 May, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays »

4 May, 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management

26 February, 2009
New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Microbiology Data Management System now Available Worldwide

7 July, 2008
BD GeneOhm™ Cdiff Assay CE Marked and Submitted for FDA Clearance

2 June, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections

17 March, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates